New Pill Shows Promise in Slowing Early Alzheimer's Progression
TL;DR Summary
A Phase 3 trial of the investigational drug valiltramiprosate shows promise in slowing neurodegeneration in genetically high-risk Alzheimer's patients with APOE4/4, especially when administered early at the MCI stage, though it did not meet its primary clinical endpoint overall.
Early-stage Alzheimer's: New pill slows down neurodegeneration MedicalNewsToday
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
6 min
vs 7 min read
Condensed
97%
1,203 → 39 words
Want the full story? Read the original article
Read on MedicalNewsToday